Atara Biotherapeutics
ATRA
ATRA
115 hedge funds and large institutions have $1.92B invested in Atara Biotherapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 124 → 115 (-9)
29% less call options, than puts
Call options by funds: $3.53M | Put options by funds: $4.96M
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
115
Holding in Top 10
3
Calls
$3.53M
Puts
$4.96M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$10.3M | |
| 3 | +$10.2M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.98M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$7.35M |
Top Sellers
| 1 | -$39.4M | |
| 2 | -$12.3M | |
| 3 | -$7.35M | |
| 4 |
Morgan Stanley
New York
|
-$6.28M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.28M |